The Paradigm of Targeting an Oncogenic Tyrosine Kinase: Lesson from BCR-ABL | IntechOpen
Targeting the SH2-Kinase Interface in Bcr-Abl Inhibits Leukemogenesis: Cell
A model for the regulation of BCR-ABL nuclear import through conformational interplay between the kinase domain, the FABD and the NLS region.
Flying under the radar: the new wave of BCR–ABL inhibitors | Nature Reviews Drug Discovery
STI571: an inhibitor of the BCR-ABL tyrosine kinase for the treatment of chronic myelogenous leukaemia - The Lancet Oncology
Disabling Abl—Perspectives on Abl kinase regulation and cancer therapeutics: Cancer Cell
The tyrosine kinase c-Abl potentiates interferon-mediated antiviral immunity by STAT1 phosphorylation - ScienceDirect
Figure 1 from STI571: targeting BCR-ABL as therapy for CML. | Semantic Scholar
Allosteric Inhibition of Bcr-Abl Kinase by High Affinity Monobody Inhibitors Directed to the Src Homology 2 (SH2)-Kinase Interface* - Journal of Biological Chemistry
Tyrosine-kinase inhibition in treatment of chronic myeloid leukaemia - The Lancet
BCR-ABL1 and the Philadelphia chromosome - Part 3: The BCR-ABL fusion protein - YouTube
Targeting the BCR-ABL Tyrosine Kinase in Chronic Myeloid Leukemia | NEJM
Bcr-Abl and Imatinib (STI571 or Gleevec) - Proteopedia, life in 3D
Bcr-Abl阻害 | Bcr-Abl Inhibition
Mechanism of action of BCR (breakpoint cluster region)-ABL (Abelson 1... | Download Scientific Diagram
Imatinib resistance in chronic myeloid leukaemia caused by Bcr-Abl kinase domain and non-Bcr-Abl mutations: a comparison and review. - Australian Medical Student Journal
Hematology Reports | Free Full-Text | Outcomes of the Pregnancies with Chronic Myeloid Leukemia in the Tyrosine Kinase Inhibitor Era and Literature Review
Schematic representation of the mechanism of action of the BCR-ABLTKIs.... | Download Scientific Diagram
Regulation of the c-Abl and Bcr–Abl tyrosine kinases | Nature Reviews Molecular Cell Biology
Frontiers | The Discovery of Novel BCR-ABL Tyrosine Kinase Inhibitors Using a Pharmacophore Modeling and Virtual Screening Approach
Mechanism of Action of BCR-ABL and of Its Inhibition by Imatinib. Panel... | Download Scientific Diagram
BCR-ABL activates multiple downstream signaling pathways that... | Download Scientific Diagram
Structure and Dynamic Regulation of Abl Kinases* - ScienceDirect
Second generation inhibitors of BCR-ABL for the treatment of imatinib-resistant chronic myeloid leukaemia | Nature Reviews Cancer
